The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro

Neuroscience

Volumn 93, Issue 1, 1999, Pages 57-69

  Coogan, A N ^a   O'Neill, L A J ^b   O'Connor, J J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Ceramide; Hippocampus; LTP; NMDA EPSP; P38 MAP kinase; SB203580

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CERAMIDE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NEUROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SYNAPTIC TRANSMISSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DENTATE GYRUS; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; FLAVONOIDS; IMIDAZOLES; INDOMETHACIN; INTERLEUKIN-1; LONG-TERM POTENTIATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERFORANT PATHWAY; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0033057788     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00100-1     Document Type: Article

References (62)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. biol. Chem. 270:1995;27,489-27,494.
2. Bailey C.H., Kandel E.R. Structural changes accompanying memory storage. A. Rev. Physiol. 55:1993;397-426.
3. Ban E., Milon G., Prudhom N., Fillion G., Haour F. Receptors for interleukin-1 (α and β) in mouse brain: mapping and neuronal localisation in hippocampus. Neuroscience. 43:1991;21-30.
4. Bellinger F.P., Madamba S., Siggins G.R. Interleukin-1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:1993;227-234.
5. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-38.
6. Boland M.P., O'Neill L.A.J. Ceramide activates NF-kB by inducing processing of p105. J. biol. Chem. 273:1998;15,494-15,550.
7. Borsch-Haubold A.G., Kramer R.M., Watson S.P. Phosphorylation and activation of cytosolic phospholipase A2 by a 38 KDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur. J. Biochem. 245:1997;751-759.
8. Brenner B., Koppenhoefers U., Weinstock C., Linderkamp O., Lang F., Gulbins E. Fas- or ceramide-induced apoptosis is mediated by a rac-1-regulated activation of jun-N-terminal kinases/p38 kinases and GADD153. J. biol. Chem. 272:1997;22,173-22,181.
9. 2+ concentration by interleukin-1β in cortical synaptosomes: involvement of a pertussis toxin-sensitive G-protein and mitogen-activated protein kinase. NeuroReport. 9:1998;1923-1927.
10. Carletti R., Tacoconi S., Bettini E., Ferraguti F. Stress activated protein kinases, a novel family of mitogen-activated protein kinases, are heterogenously expressed in the adult rat brain and differentially distributed from extracellular-signal-regulated protein kinases. Neuroscience. 69:1995;1100-1103.
11. Coogan A., O'Connor J.J. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β NeuroReport. 8:1997;2107-2110.
12. Coogan A.N., O'Leary D.M., O'Connor J.J. The p42/44 MAP kinase inhibitor PD98059 attenuates multiple forms of synaptic plasticity in the rat dentate gyrus in vitro. J. Neurophysiol. 81:1999;103-110.
13. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. Fedn Eur. biochem. Socs Lett. 364:1995;229-233.
14. Cunningham A.J., Murray C.A., O'Neill L.A.J., Lynch M.A., O'Connor J.J. Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203:1997;1-4.
15. English J.D., Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long-term potentiation. J. biol. Chem. 272:1997;19,103-19,106.
16. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain. Molec. Brain Res. 30:1995;125-130.
17. Furaya S., Hirabayashi Y. Ceramide activates JNK/SAPK in cerebellar neurons. Soc. Neurosci. Abstr. 27:1997;466.6.
18. Furukawa K., Mattson M.P. The transcription factor NF-kB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumour necrosis factor-α in hippocampal neurons. J. Neurochem. 70:1998;1876-1886.
19. Guan Z., Baier L.D., Morrison A.R. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β J. biol. Chem. 272:1997;8083-8089.
20. Guan Z., Buckman S.Y., Pentland A.P., Templeton D.J., Morrison A.R. Induction of cyclooxygenase-2 by the activation of MEKK1-SEK1/MKK4-p38 mitogen-activated protein kinase pathway. J. biol. Chem. 273:1998;12,901-12,908.
21. Haimovitz-Friedman A., Kolesnick R.N., Fuks Z. Ceramide signalling in apoptosis. Br. med. Bull. 53:1997;539-553.
22. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system I: expression and recognition. Trends Neurosci. 18:1995;83-88.
23. Katuski H., Nakai S., Hirai Y., Akaji K., Kiso Y., Satoh M. Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmac. 181:1990;323-326.
24. Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y., Nishida E. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. biol. Chem. 272:1997;18,518-18,521.
25. Komaki G., Arimura A., Koves K. Effect of intravenous injection of IL-1β on PGE2 levels in several brain areas as determined by microdialysis. Am. J. Physiol. 262:1992;E246-E251.
26. Kramer R.M., Roberts E.F., Um S.L., Borsch-Haubold A.G., Watson S.P., Fisher M.J., Jakubowski J.A. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin. J. biol. Chem. 27:1996;27,723-27,729.
27. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. biol. Chem. 271:1996;24,313-24,316.
28. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induced expression of cytokine transcripts in the brain and pituitary of mice. Molec. Brain Res. 27:1994;157-162.
29. Lin L.-L., Wartman L., Lin A.Y., Knopf J.L., Seth A., Davis R.J. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.
30. Maroney A.C., Glicksman M.A., Basma A.N., Walton K.M., Knight E., Murphy C.A., Bartlett B.A., Finn J.P., Angeles T., Mastuda Y., Neff N.T., Dionne C.A. Motorneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signalling pathway. J. Neurosci. 18:1998;104-111.
31. Maruta E., Yabuuchi K., Nishiyori A., Takami S., Minami M., Satoh M. B2-adrenoceptors on the glial cells mediate induction of interleukin-1β mRNA in the rat brain. Molec. Brain Res. 49:1997;291-294.
32. McHowat J., Liu S. Interleukin-1β stimulates phospholipase A2 activity in adult rat ventricular myocytes. Am. J. Physiol. 272:1997;C450-C456.
33. McNaughton B.L. Evidence for physiologically distinct perforant pathways to the fascia dentata. Brain Res. 199:1980;1-19.
34. Murray C.A., Lynch M.A. Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18:1998;2974-2981.
35. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., Maier S.F. Exposure to acute stress induces brain interleukin-1β protein in the rat. J. Neurosci. 18:1998;2239-2246.
36. Nishiyori A., Minami M., Takami S., Satoh M. Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Molec. Brain Res. 50:1997;237-245.
37. O'Connor J.J., Rowan M.J., Anwyl R. Long-lasting enhancement of NMDA receptor-mediated synaptic transmission by metabotropic glutamate receptor activation. Nature. 367:1994;557-559.
38. O'Neill L.A.J. Towards an understanding of the signal transduction pathways for interleukin-1. Biochim. biophys. Acta. 1266:1995;31-44.
39. O'Neill L.A.J., Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signalling machinery in mammals, insects and plants. J. Leukoc. Biol. 63:1998;650-657.
40. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cell induced by nerve growth factor. J. biol. Chem. 270:1995;13,585-13,588.
41. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmyer J.A., Dantzer R., Kelley K.W. Expression of type I and type II interleukin-1 receptors in mouse brain. Molec. Brain Res. 27:1994;63-70.
42. Platta-Salaman C.R., Ffrench-Mullen J.M.H. Interleukin-1β depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res. Bull. 29:1992;221-223.
43. Platta-Salaman C.R., Ffrench-Mullen J.M.H. Interleukin-1β inhibits calcium channel currents in hippocampal neurons through protein kinase C. Eur. J. Pharmac. 266:1994;1-10.
44. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Hans J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. biol. Chem. 270:1995;7420-7426.
45. Reunanen N., Westermarck J., Hakkinen L., Holmstrom T.H., Elo I., Eriksson J.E., Kahari V.-M. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. biol. Chem. 273:1998;5137-5145.
46. Reynolds C.H., Nebreda A.R., Gibb G.M., Utton M.A., Anderton B.H. Reactivating kinase/p38 phosphorylates Tau protein in vitro. J. Neurochem. 69:1997;191-198.
47. Ridley S.H., Sarsfield S.J., Lee J.C., Bigg H.F., Cawston T.E., Taylor D.J., DeWitt D.L., Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. J. Immun. 158:1997;3165-3173.
48. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18:1995;130-136.
49. Rothwell N., Allan S., Toulmond S. The role of interleukin-1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. clin. Invest. 100:1998;2648-2652.
50. Rousseau S., Houle K., Landry S., Hout S. p38 map kinase activation by vascular endothelial growth factor mediated actin reorganisation and cell migration in human endothelial cells. Oncogene. 15:1997;2169-2177.
51. Saklatvala J., Davis W., Guesdon F. Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction. Phil. Trans. R. Soc. Lond. 351:1996;151-157.
52. Schneider H., Prossi F., Balschun D., Wagner A., Del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1β in the hippocampus. Proc. natn. Acad. Sci. U.S.A. 95:1998;7778-7783.
53. Seger R., Krebs E.G. The MAPK signalling cascade. Fedn Am. Socs exp. Biol. J. 9:1995;726-735.
54. Sonti G., Ilyin S.E., Platta-Salaman C.R. Anorexia induced by cytokine: interactions at pathophysiological concentrations. Am. J. Physiol. 270:1996;R1394-R1402.
55. Takao T., Tracey D.E., Mitchell W.M., De Souza E.B. Interleukin-1 receptors in mouse brain: characterisation and neuronal localization. Endocrinology. 127:1990;3070-3078.
56. Takao T., Nagano I., Tojo C., Takemura T., Makino S., Hashimoto K., Desouza E.B. Age-related reciprocal modulation of interleukin-1β and interleukin-1 receptors in the mouse brain-endocrine-immune axis. Neuroimmunomodulation. 3:1997;205-212.
57. Wheal H.V., Chen Y., Mitchell J., Schachner M., Maerz W., Wieland H., Van Rossum D., Kirsch J. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Prog. Neurobiol. 55:1998;611-640.
58. Wilk-Blaszczak M.A., Stein B., Xu S., Barbosa M.S., Cobb M.H., Belardetti F. The mitogen-activated protein kinase p38-2 is necessary for the inhibition of N-type calcium currents by bradykinin. J. Neurosci. 18:(1):1998;112-118.
59. Wilsch V.W., Behnisch T., Jager T., Reymann K.G., Balschun D. When are class I metabotropic glutamate receptors necessary for long-term potentiation? J. Neurosci. 18:1998;6071-6080.
60. Wilson K.P., McCaffery P.G., Hsiao K., Pazhanisamy S., Gallulo V., Bemis G.W., Fitzgibbon M.J., Curon P.R., Muckro M.A., Su M.S. The structural basis for specificity of pyridinylimidazole inhibitors of p38 MAPK. Chem. Biol. 4:1997;423-431.
61. Zeise M.L., Madamba S., Siggins G.R. Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regul. Pept. 39:1992;1-7.
62. Zeise M.L., Espinoza J., Morales P., Nalli A. Interleukin-1β does not increase synaptic inhibition in hippocampal pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res. 768:1998;341-344.